<DOC>
	<DOCNO>NCT02043977</DOCNO>
	<brief_summary>Insomnia widespread condition approximately one-third adult United States symptomatic 6 % population meeting diagnostic criterion insomnia . There increase risk insomnia certain segment population include woman , middle-aged older adult , shift worker individual medical psychiatric disorder . Individuals insomnia decrease quality life compare report serious illness major depression congestive heart failure . Chronic insomnia cause medication , drug alcohol abuse , psychiatric disorder , medical neurologic disorder . It impair cognitive physical functioning . Propofol approve drug administer intravenously use induction maintenance anesthesia sedation . Some research suggest propofol administer two hour infusion may improve ease sleep onset , sleep quality , ease awaken integrity behavior follow waking . This study conduct Broward Health Medical Center Sleep Lab , direct care Board Certified Anesthesiologist , dedicate study involve participant refractory chronic primary insomnia respond conventional pharmacologic therapy within past 90 day . Each qualify participant receive IV infusion study medication 5 consecutive night . Assessments include polysomnography completion questionnaires occur screening , Days 1 5 study product administration , Day 6 Day 90 . Follow-up questionnaire also distribute Day 180 .</brief_summary>
	<brief_title>Efficacy Safety Study Propofol Infusion Refractory Chronic Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Ambulatory , male nonpregnant , nonlactating female , 1865 year age . Overall healthy sleep disorder sleep apnea periodic limb movement disorder Has respond conventional pharmacologic therapy ( benzodiazepine nonbenzodiazepines ) within past 90 day . The nonbenzodiazepine therapy include melatonin melatonin receptor agonist , antihistamine , antidepressant , overthecounter medication , supplement herbs sleep Have refractory chronic primary insomnia ( chronicinadequate quantity quality sleep characterize subjective report difficulty sleep initiation , duration , consolidation , quality occur despite adequate opportunity sleep , result form daytime impairment persist least one month. , primaryinsomnia independent know physical mental condition , refractorynot yielding , least yield readily treatment base upon polysomnography baseline , total sleep time ( sTST ) &lt; 6 hr , subjective wake time sleep onset ( WASO ) &gt; 1 hr , subjective latency sleep onset ( SOL ) &gt; 20 min Willing able give write informed consent Clearly understand procedure requirement study Willing able comply study procedure data record obligation entire length study Have clinically significant abnormality basis medical history , physical examination vital sign judgment investigator and/or subinvestigator Ability willingness abstain pharmaceutical overthecounter medication sleep well alcohol 72 hour prior baseline first dose completion Study Product Administration FollowUp Visit ( Day 6 ) well 72 hour prior Day 90 visit . All value hematology clinical chemistry test blood within normal range age gender show clinically relevant deviation judge investigator Nonsmoking quit smoking least 6 month prior dose Having medical condition include diabetes , cardiovascular disease , pulmonary , renal , endocrine , hepatic , neurologic , psychiatric ( include depression ) , immunologic , hematologic , gastrointestinal metabolic disease require medical treatment would preclude participation study judgment investigator/subinvestigator Having ingest pharmaceutical overthecounter sleep product within 72 hour dose well 72 hour prior Day 90 visit . Taking medication yield moderate major drug interaction propofol include CNS ( central nervous system ) depressant effect Having history medical surgical procedure would preclude participation study judgment investigator/subinvestigator Being pregnant , plan become pregnant , breast feeding unwilling use medically acceptable form birth control study ( least one acceptable barrier period one month prior begin study least three month study completion ) surgically sterile postmenopausal ( least 12 month without period ) . Having systolic blood pressure &gt; 160 mmHg , diastolic blood pressure &gt; 90 mmHg , blood pressure would preclude participation judgment investigator/subinvestigator Having previous history abnormal screen laboratory test value : bilirubin &gt; 2 x ULN ( upper limit normal ) , AST ( aspartate aminotransferase ) ALT ( alanine aminotransferase ) &gt; 2 x ULN ( upper limit normal ) , serum creatinine &gt; 1.5 mg/dl , fast blood glucose 85mg/dl 110 mg/dl , calcium level &lt; 8.6 mg/dl triglyceride &gt; 200.0mg/dl . Any type active malignancy ( except nonmelanomatous skin malignancy ) within past 5 year History know suspect substance abuse Currently consume 7 standard alcoholic drink per week unable refrain consume alcoholic beverage course study dose period . Currently consume 14 caffeinated beverage per week unable refrain consume caffeinated beverage within 8 hour prior dose . History allergy anesthetic , egg , egg product , soybean soy product well hypersensitivity Propofol component Unable avoid engage hazardous occupation require complete mental alertness and/or motor coordination receive study product . Participation another study within 30 day prior dose . Donated blood within 30 day prior dose . Illness within five day prior dose Having pacemaker internal medical device In opinion investigator , suitable entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Propofol</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Sleep disorder</keyword>
	<keyword>Sleep deprivation</keyword>
	<keyword>Chronic insomnia</keyword>
	<keyword>Refractory insomnia</keyword>
	<keyword>Primary insomnia</keyword>
</DOC>